Home
Indoco Remedies Ltd 52 Week High

Indoco Remedies Ltd
NSE: INDOCO
YEARHIGH
Key Highlights
- The 52 Week HIGH of Indoco Remedies Ltd is ₹ 385.5 as of 30 Apr 25 .
Company Fundamentals for Indoco Remedies Ltd
Market Price of Indoco Remedies Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
30 Apr 2025 | 232.5 |
29 Apr 2025 | 226.65 |
28 Apr 2025 | 231.05 |
25 Apr 2025 | 232.15 |
24 Apr 2025 | 238.9 |
23 Apr 2025 | 240.95 |
22 Apr 2025 | 246.15 |
21 Apr 2025 | 242.15 |
17 Apr 2025 | 239.25 |
16 Apr 2025 | 239.95 |
Asset Value vs Market Value of Indoco Remedies Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Indoco Remedies Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Indoco Remedies Ltd
Historical Net Profit of Indoco Remedies Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Indoco Remedies Ltd
Indoco Remedies Ltd News Hub
Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg
Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New Drug Appl
Read more
21 Aug 24
Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets
The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been granted a Comp
Read more
21 Aug 24
Indoco Remedies fixes record date for final dividend
Indoco Remedies has fixed 19 September 2024 as record date for determining entitlement of members to
Read more
30 Aug 24
Indoco Remedies AGM scheduled
Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be held on 26 Se
Read more
31 Aug 24